FDA Approved: SAFYRAL — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium) filed by Bayer HealthCare Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Neural Tube Defects Prevention

Drugs mentioned

• SAFYRAL (DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM)

Snippet

SUPPL AP for SAFYRAL (DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM)